MTCH.NASDAQMatch Group, INC

Form 4: Pamela Seymon, Match Group Director, Reports Acquisition of Dividend Equivalents

Sentiment:

SEC Form 4 Filing


Match Group director Pamela Seymon reports acquiring dividend equivalents convertible to 53 shares of common stock.

Summary

  • Pamela Seymon, a director at Match Group, Inc., filed a Form 4 with the SEC.
  • The filing reports the acquisition of 53 dividend equivalents on April 17, 2025.
  • These dividend equivalents will convert into common stock on a one-for-one basis.
  • The dividend equivalents accrued on restricted stock units that vest on the earlier of June 21, 2025, or the date of the next Annual Stockholder Meeting of Match Group, Inc. following the grant date, subject to continued service.
  • The reporting person directly owns the dividend equivalents.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to dividend equivalents, so the sentiment is neutral.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock. This allows the public to see if those with inside knowledge of the company are buying or selling shares, which can be an indicator of the company's future prospects.

Key Dates

DateDescription
04/17/2025Date of transaction: Acquisition of dividend equivalents
04/21/2025Date of signature on the report
06/21/2025Earliest vesting date for restricted stock units associated with the dividend equivalents

Keywords

Form 4, Match Group, Dividend Equivalents, Beneficial Ownership, Director, Seymon, MTCH

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.